Earnings call transcript for Q4 FY26 Financial Results.
MOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Meghmani Organics reported FY26 standalone revenue of INR 2,091 crores (up 4% Y-o-Y) and EBITDA of INR 228.7 crores (up 27% Y-o-Y). Q4 performance was impacted by geopolitical headwinds and rising raw material costs (especially sulphuric acid), which squeezed margins. The company established a Brazil subsidiary to access the $15 billion agrochemical market. It received government approval for Nano DAP, Nano NPK, and Nano Zinc products, expected to launch in Kharif season. The Titanium Dioxide plant was suspended due to unviable economics from elevated input costs. Management expects FY27 double-digit revenue growth in Crop Protection and maintained long-term EBITDA margin guidance of 15-17% for the segment. A scheme of amalgamation for Kilburn Chemicals and Meghmani Crop Nutrition is underway.
The company navigated challenging macro conditions in FY26 with solid EBITDA growth. For FY27, investors can expect improved profitability driven by Crop Protection segment recovery and better Pigments performance, with management committing to resume dividends after a 2-year hiatus.